MSB.AX · MESOBLAST LIMITED
Australia · RS rating 36 · As of 2026-10-14
| Price | 1.99 AUD |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 36 / 52 / 23 / 44 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 20 / 13 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +35.2% |
| Market cap (USD) | $1.8B |